BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

247 related articles for article (PubMed ID: 18783295)

  • 1. Influence of burns on pharmacokinetics and pharmacodynamics of drugs used in the care of burn patients.
    Blanchet B; Jullien V; Vinsonneau C; Tod M
    Clin Pharmacokinet; 2008; 47(10):635-54. PubMed ID: 18783295
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Gap analysis of pharmacokinetics and pharmacodynamics in burn patients: a review.
    Steele AN; Grimsrud KN; Sen S; Palmieri TL; Greenhalgh DG; Tran NK
    J Burn Care Res; 2015; 36(3):e194-211. PubMed ID: 25942648
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Pharmacokinetics and pharmacodynamics of antibacterial and antifungal agents in adult patients with thermal injury: a review of current literature.
    Ortwine JK; Pogue JM; Faris J
    J Burn Care Res; 2015; 36(2):e72-84. PubMed ID: 25167375
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Clinical pharmacokinetics in patients with burns.
    Jaehde U; Sörgel F
    Clin Pharmacokinet; 1995 Jul; 29(1):15-28. PubMed ID: 7586895
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Pharmacokinetic and pharmacodynamic considerations when treating patients with sepsis and septic shock.
    De Paepe P; Belpaire FM; Buylaert WA
    Clin Pharmacokinet; 2002; 41(14):1135-51. PubMed ID: 12405864
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Intravenous Antibiotic and Antifungal Agent Pharmacokinetic-Pharmacodynamic Dosing in Adults with Severe Burn Injury.
    Cota JM; FakhriRavari A; Rowan MP; Chung KK; Murray CK; Akers KS
    Clin Ther; 2016 Sep; 38(9):2016-31. PubMed ID: 27586127
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Clinical pharmacology of muscle relaxants in patients with burns.
    Martyn J; Goldhill DR; Goudsouzian NG
    J Clin Pharmacol; 1986; 26(8):680-5. PubMed ID: 2947935
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Antimicrobial treatment in burn injury patients].
    Trupkovic T; Gille J; Fischer H; Kleinschmidt S
    Anaesthesist; 2012 Mar; 61(3):249-51, 254-6, 258. PubMed ID: 22430556
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Burns and epilepsy--review and case report.
    Gragnani A; Müller BR; Oliveira AF; Ferreira LM
    Burns; 2015 Mar; 41(2):e15-8. PubMed ID: 25440855
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pharmacokinetics and Pharmacodynamics of Antimicrobial Agents in Burn Patients.
    Pruskowski KA
    Surg Infect (Larchmt); 2021 Feb; 22(1):77-82. PubMed ID: 33164665
    [No Abstract]   [Full Text] [Related]  

  • 11. Pharmacokinetics of antibiotics in burn patients.
    Weinbren MJ
    J Antimicrob Chemother; 1999 Sep; 44(3):319-27. PubMed ID: 10511398
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Pathophysiology and pharmacokinetics following burn injury.
    Bonate PL
    Clin Pharmacokinet; 1990 Feb; 18(2):118-30. PubMed ID: 2180612
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Pharmacokinetics and pharmacodynamics of vecuronium in children receiving phenytoin or carbamazepine for chronic anticonvulsant therapy.
    Soriano SG; Sullivan LJ; Venkatakrishnan K; Greenblatt DJ; Martyn JA
    Br J Anaesth; 2001 Feb; 86(2):223-9. PubMed ID: 11573664
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Pharmacokinetics of drugs used in critically ill adults.
    Power BM; Forbes AM; van Heerden PV; Ilett KF
    Clin Pharmacokinet; 1998 Jan; 34(1):25-56. PubMed ID: 9474472
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Acute renal insufficiency caused by burn injury].
    Zogović J; Mladenović Lj
    Srp Arh Celok Lek; 1996; 124(9-10):241-5. PubMed ID: 9102856
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Lack of pharmacokinetic interaction between lansoprazole and intravenously administered phenytoin.
    Karol MD; Locke CS; Cavanaugh JH
    J Clin Pharmacol; 1999 Dec; 39(12):1283-9. PubMed ID: 10586395
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Management of severe burns during the 1st 72 hours].
    Gueugniaud PY
    Ann Fr Anesth Reanim; 1997; 16(4):354-69. PubMed ID: 9750581
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Drug interactions with clinafloxacin.
    Randinitis EJ; Alvey CW; Koup JR; Rausch G; Abel R; Bron NJ; Hounslow NJ; Vassos AB; Sedman AJ
    Antimicrob Agents Chemother; 2001 Sep; 45(9):2543-52. PubMed ID: 11502527
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Vecuronium pharmacokinetics in patients with major burns.
    Vega-Villa KR; Kaneda K; Yamashita S; Woo S; Han TH
    Br J Anaesth; 2014 Feb; 112(2):304-10. PubMed ID: 24067332
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The effects of major burn related pathophysiological changes on the pharmacokinetics and pharmacodynamics of drug use: An appraisal utilizing antibiotics.
    Udy AA; Roberts JA; Lipman J; Blot S
    Adv Drug Deliv Rev; 2018 Jan; 123():65-74. PubMed ID: 28964882
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.